Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma

M. Khaitov, A. Babakhin, I. Shilovsky, I. Andreev, L. Koz‘min, A. Martynov (Moscow, Russian Federation)

Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Session: Animal models of asthma and lung inflammation
Session type: E-Communication Session
Number: 5647
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Khaitov, A. Babakhin, I. Shilovsky, I. Andreev, L. Koz‘min, A. Martynov (Moscow, Russian Federation). Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma. Eur Respir J 2010; 36: Suppl. 54, 5647

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007

The effect of Der f-induced airway inflammation on airway inflammation in a murine model of allergic asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 348s
Year: 2004

Estrogen prevents airway hyperresponsiveness in a murine model of allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 433s
Year: 2006

A role of fungal extracts on allergic airway inflammation in the ovalbumin-induced asthma model
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Obesity enhances allergen-induced airway inflammation in a murine model of asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019

Effects of OVA-induced allergic airway inflammation and remodeling in mice in three distinct asthma models
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010


Effects of IL-4Rα blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice
Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Year: 2008

Effects of active and passive smoking on allergic airway inflammation and airway hyperresponsiveness in mice
Source: Eur Respir J 2002; 20: Suppl. 38, 310s
Year: 2002

Comparison of late allergic inflammatory responses in asthma and rhinitis after nasal and bronchial allergen challenge
Source: Eur Respir J 2001; 18: Suppl. 33, 269s
Year: 2001

Sublingual monomeric allergoid immunotherapy improves airway inflammation, airway hyperresponsiveness and clinical symptoms in allergic rhinitis and asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 439s
Year: 2006

Young Investigator session: ROR?t-specific RNAi decreases allergic airway inflammation and airway hyperresponsiveness in a mouse model of neutrophilic asthma
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014

Effect of previous physical conditioning on pulmonary inflammation and allergic immune response in a chronic allergic airway inflammation in mice
Source: Eur Respir J 2007; 30: Suppl. 51, 370s
Year: 2007

Analysis of mucus production in mouse models of allergic asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010

Narirutin inhibits airway inflammation in an allergic mouse model
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

The development of an airway hyperresponsiveness (AHR) depends on mast cells following sensitization without adjuvant
Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis
Year: 2006


Effects of budesonide/formoterol maintenance therapy on airway hyperresponsiveness and inflammation in an allergic rat model
Source: Eur Respir J 2004; 24: Suppl. 48, 351s
Year: 2004

Effect of nasal allergen challenge on non-invasive markers of inflammation in allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 592s
Year: 2006

The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007


The PAR2-activating peptide SLIGRL inhibits airway hyper-responsiveness and eosinophilia in an acute murine model of allergic asthma
Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology
Year: 2004


MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 20s
Year: 2001